Eli Lilly pauses COVID-19 antibody trial due to safety concern

by
from Al Jazeera – Breaking News, World News and Video from Al Jazeera on (#592QH)
The US pharmaceutical company announces it is pausing enrolment in its trial 'out of an abundance of caution'.
External Content
Source RSS or Atom Feed
Feed Location https://www.aljazeera.com/xml/rss/all.xml
Feed Title Al Jazeera – Breaking News, World News and Video from Al Jazeera
Feed Link https://www.aljazeera.com/
Feed Copyright © 2026 Al Jazeera Media Network
Reply 0 comments